zoledronic acid has been researched along with Joint Pain in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kushima, C; Nakazato, M; Uchida, T; Yamaguchi, H; Yonekawa, T | 1 |
| Aitken, D; Cai, G; Cicuttini, F; Hill, C; Jones, G; Laslett, LL; March, L; Martel-Pelletier, J; Pelletier, JP; Wluka, AE | 1 |
| Appelt, KA; Meier, C; Müller, F; Suhm, N | 1 |
| Dalla-Pozza, L; Little, DG; Munns, CF; Padhye, B | 1 |
| Ashraf, S; Bennett, AJ; Burston, JJ; Chapman, V; Menhinick, MR; Poulter, CL; Sagar, DR; Walsh, DA; Xu, L | 1 |
| Andréu Sánchez, JL; Barbadillo Mateos, C; Blanco, R; Campos Esteban, J; Espinosa-Malpartida, M; Flores-Robles, BJ; Godoy-Tundidor, H; Huntley-Pascual, D; Isasi, CM; Jiménez-Palop, MM; Merino-Argumanez, C; Mulero, JB; Ramos-Giráldez, MC; Sanabria-Sanchinel, AA; Sanz-Sanz, J; Villa-Alcázar, LF | 1 |
| Bensen, W; Chiodo, J; de Villiers, TJ; Mesenbrink, P; Recknor, C; Ryabitseva, O; Wark, JD | 1 |
| Bauer, JS; Beck, N; Eitner, S; Kiefer, J; Stockmann, P; Wichmann, M | 1 |
| Boon, P; Doré, DA; Jones, G; Laslett, LL; Quinn, SJ; Ryan, E; Winzenberg, TM | 1 |
| Becker, S; Fehm, T; Gebauer, G; Hirnle, P; Huober, J; Janni, W; Krämer, B; Lück, HJ; Solomayer, EF; Wackwitz, B; Wallwiener, D | 1 |
| Decker, JL; Henderson, C; Hohneker, JA; Kaplan, BH; Lacerna, L; Orlowski, R; Purdy, MH; Schnell, FM; Vogel, CL; Wood, AJ; Yanagihara, RH | 1 |
| Aroni, K; Batziou, K; Manoussakis, MN; Mavragani, CP; Pikazis, D | 1 |
4 trial(s) available for zoledronic acid and Joint Pain
| Article | Year |
|---|---|
Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg.
Topics: Acetaminophen; Aged; Arthralgia; Body Temperature; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fever; Headache; Humans; Ibuprofen; Imidazoles; Middle Aged; Nausea; Osteoporosis, Postmenopausal; Severity of Illness Index; Treatment Outcome; Zoledronic Acid | 2012 |
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
Topics: Acute-Phase Reaction; Aged; Arthralgia; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Infusions, Intravenous; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Outcome Assessment, Health Care; Pain Measurement; Treatment Outcome; Zoledronic Acid | 2012 |
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Arthralgia; Bone Marrow Cells; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Treatment Outcome; Zoledronic Acid | 2012 |
Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.
Topics: Aged; Arthralgia; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Creatinine; Diphosphonates; Fatigue; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Nausea; Pain; Pain Measurement; Prospective Studies; Prostatic Neoplasms; Quality of Life; Treatment Outcome; Zoledronic Acid | 2004 |
8 other study(ies) available for zoledronic acid and Joint Pain
| Article | Year |
|---|---|
Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
Topics: Ankle; Anorexia; Antithyroid Agents; Aromatase Inhibitors; Arthralgia; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Collagen Type I; Denosumab; Deprescriptions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Graves Disease; Humans; Hypercalcemia; Methimazole; Middle Aged; Parathyroid Hormone; Peptides; Potassium Iodide; Radionuclide Imaging; Tartrate-Resistant Acid Phosphatase; Thirst; Zoledronic Acid | 2020 |
The association between change in bone marrow lesion size and change in tibiofemoral cartilage volume and knee symptoms.
Topics: Arthralgia; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Diseases; Cartilage, Articular; Double-Blind Method; Female; Femur; Glucocorticoids; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multicenter Studies as Topic; Osteoarthritis, Knee; Randomized Controlled Trials as Topic; Tibia; Time Factors; Zoledronic Acid | 2021 |
Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.
Topics: Aged; Arthralgia; Biomarkers; Bone Density Conservation Agents; Bone Marrow Diseases; Collagen Type I; Denosumab; Dietary Supplements; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Retrospective Studies; Vitamin D; Zoledronic Acid | 2020 |
Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis.
Topics: Adolescent; Arthralgia; Arthroplasty; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Humans; Imidazoles; Lymphoma; Male; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Retrospective Studies; Time Factors; Zoledronic Acid | 2013 |
Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis.
Topics: Animals; Arthralgia; Behavior, Animal; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Disease Models, Animal; Drug Design; Enzyme Inhibitors; Imidazoles; Iodoacetic Acid; Joints; Male; Nociceptors; Osteoarthritis; Osteoclasts; Osteophyte; Osteoprotegerin; Rats; Rats, Sprague-Dawley; Spinal Cord; Zoledronic Acid | 2014 |
Zoledronic Acid Treatment in Primary Bone Marrow Edema Syndrome.
Topics: Adult; Aged; Arthralgia; Bone Density Conservation Agents; Bone Marrow; Databases, Factual; Diphosphonates; Edema; Female; Humans; Imidazoles; Male; Middle Aged; Retrospective Studies; Syndrome; Zoledronic Acid | 2017 |
Awareness and education of patients receiving bisphosphonates.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Arthralgia; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Breast Neoplasms; Dental Care; Dentist-Patient Relations; Dentists; Diphosphonates; Drug Labeling; Female; Gastrointestinal Diseases; Health Knowledge, Attitudes, Practice; Health Literacy; Humans; Imidazoles; Injections, Intravenous; Interprofessional Relations; Male; Middle Aged; Osteoporosis; Patient Education as Topic; Physician-Patient Relations; Physicians; Prostatic Neoplasms; Risk Factors; Zoledronic Acid | 2012 |
Alleviation of polyarticular syndrome in multicentric reticulohistiocytosis with intravenous zoledronate.
Topics: Arthralgia; Diphosphonates; Female; Hand Deformities, Acquired; Histiocytosis, Non-Langerhans-Cell; Humans; Imidazoles; Middle Aged; Syndrome; Zoledronic Acid | 2005 |